tiletamine hydrochloride has been researched along with Obesity in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Chattipakorn, N; Chen, X; Feng, J; Guan, X; Jin, L; Liang, G; Luo, W; Pavlov, VN; Samorodov, AV; Wang, M; Wang, Y; Yang, D; Ye, L; Zhuang, Z | 1 |
| Aldámiz-Echevarría, L; Bueno, M; Couce, ML; Díaz-Fernández, C; García-Volpe, C; Gil, D; Hernández, T; López-Ruzafa, E; Martín-Hernández, E; Navas, V; Peña-Quintana, L; Pintos, G; Roca, I; Sánchez-Pintos, P; Sánchez-Valverde, F; Vitoria, I | 1 |
| Andreani, T; Belani, J; Bradley, P; Cao, Y; Chen, P; Cox, K; Dai, P; Dai, X; DeMong, D; Feng, KI; Gauuan, J; Greenlee, W; Grotz, D; Hwa, J; Kang, L; Kozlowski, J; Lachowicz, J; Lavey, B; Liang, M; Lin, P; Lin, SI; McNamara, P; Meng, T; Miller, M; Morrison, R; Patel, B; Sondey, C; Soriano, A; Stamford, A; Wong, J; Wong, M; Yang, DY; Yu, W; Zhai, Y; Zhang, H; Zhao, H; Zhou, G | 1 |
| Benhamou, JP; Danan, G; Pessayre, D; Rueff, B | 1 |
| Constantin, JM; Maroy, B; Moullot, P | 1 |
| Atttali, P; Bernuau, J; Degott, C; Fabre, M; Ink, O | 1 |
6 other study(ies) available for tiletamine hydrochloride and Obesity
| Article | Year |
|---|---|
Curcumin analogue C66 attenuates obesity-induced myocardial injury by inhibiting JNK-mediated inflammation.
Topics: Animals; Anti-Inflammatory Agents; Apoptosis; Benzylidene Compounds; Cardiomyopathies; Cell Line; Cyclohexanones; Cytokines; Diet, High-Fat; Disease Models, Animal; JNK Mitogen-Activated Protein Kinases; Male; Mice, Inbred C57BL; Myocarditis; Myocytes, Cardiac; NF-kappa B; Obesity; Palmitic Acid; Rats; Signal Transduction | 2021 |
Evolution of tyrosinemia type 1 disease in patients treated with nitisinone in Spain.
Topics: Adult; Child; Cognitive Dysfunction; Cyclohexanones; Delayed Diagnosis; Enzyme Inhibitors; Female; Follow-Up Studies; Humans; Infant, Newborn; Kidney Diseases; Male; Needs Assessment; Neonatal Screening; Nitrobenzoates; Obesity; Prognosis; Quality of Life; Retrospective Studies; Spain; Time-to-Treatment; Tyrosinemias | 2019 |
The discovery of N-((2H-tetrazol-5-yl)methyl)-4-((R)-1-((5r,8R)-8-(tert-butyl)-3-(3,5-dichlorophenyl)-2-oxo-1,4-diazaspiro[4.5]dec-3-en-1-yl)-4,4-dimethylpentyl)benzamide (SCH 900822): a potent and selective glucagon receptor antagonist.
Topics: Animals; Benzamides; Blood Glucose; Cyclohexanones; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diet, High-Fat; Drug Discovery; Glucagon; Mice; Mice, Inbred ICR; Obesity; Prediabetic State; Receptors, Glucagon; Spiro Compounds; Structure-Activity Relationship | 2014 |
[Acute hepatitis probably due to Plethoryl].
Topics: Adult; Chemical and Drug Induced Liver Injury; Cyclohexanes; Cyclohexanones; Diterpenes; Drug Combinations; Female; Humans; Obesity; Triiodothyronine; Vitamin A | 1984 |
[Probable side effects caused by plethoryl. Common acute hepatitis, anicteric hepatitis, cirrhosis due to hypervitaminosis A, inflammatory arthralgias].
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Chemical and Drug Induced Liver Injury; Cyclohexanes; Cyclohexanones; Diterpenes; Drug Combinations; Female; Humans; Hypervitaminosis A; Liver Cirrhosis; Middle Aged; Obesity; Triiodothyronine; Vitamin A | 1989 |
[Fatal fulminant hepatitis probably due to Plethoryl].
Topics: Adult; Chemical and Drug Induced Liver Injury; Cyclohexanes; Cyclohexanones; Diterpenes; Drug Combinations; Female; Humans; Obesity; Triiodothyronine; Vitamin A | 1986 |